Neoadjuvant chemoradiation therapy for locally advanced colorectal cancer in hypofractionation mode (case report)

Cover Page

Cite item

Full Text

Abstract

This article demonstrates the experience of successful treatment of a patient with locally advanced rectal cancer, who received a combined treatment with a non-standard course of chemoradiotherapy in hypofractionation mode according to a prolonged program. After the end of a course of chemoradiation received the complete clinical response of the tumor.

About the authors

S. I. Tkachev

N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

Author for correspondence.
24 Kashirskoe Shosse, Moscow 115 478 Russian Federation

A. S. Abduzhapparov

N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

Email: md.abror@mail.ru
24 Kashirskoe Shosse, Moscow 115 478 Russian Federation

V. A. Aliev

N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

24 Kashirskoe Shosse, Moscow 115 478 Russian Federation

Yu. A. Barsukov

N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

24 Kashirskoe Shosse, Moscow 115 478 Russian Federation

J. M. Madyarov

N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

24 Kashirskoe Shosse, Moscow 115 478 Russian Federation

References

  1. Wiggers T. Multidisciplinary treatment of locally advanced rectal cancer. Eur J Cancer 2007;5(Suppl):375–6.
  2. Sauer R., Becker H., Hohenberger W. et al. Preoperative chemo/radiotherapy as compared with post-operative chemo/radiotherapy for locally advanced rectal cancer. N Engl J Med 2004;351(17):1731–40. doi: 10.1056/NEJMoa040694.
  3. Yi Li, Ji Wang, Xiaowei Ma et al. A review of neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Int J Biol Sci 2016;12(8):1022–31. DOI: 10.7150/ ijbs.15438.
  4. Ognerubov N.A., Artamonova E.V. New approaches to the treatment of locally advanced rectal cancer. Vestnik TGU = Bulletin of Tomsk State University 2012;17(2):638–41. (In Russ.).
  5. Erlandsson J., Holm T., Pettersson D. et al. Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial. Lancet Oncol 2017;18(3):336–46. doi: 10.1016/S14702045(17)30086-4.
  6. Evans J., Bhoday J., Sizer B. et al. Results of a prospective randomised control 6 vs 12 trial: is greater tumour downstaging observed on post treatment MRI if surgery is delayed to 12-weeks versus 6-weeks after completion of neoadjuvant chemoradiotherapy. Ann Oncol 2016;27(Suppl 6):vi149 (abstr. 4520). doi: 10.1093/annonc/mdw370.01.
  7. Lefevre J.H., Mineur L., Kotti S. et al. Effect of interval (7 or 11 weeks) between neoadjuvant radiochemotherapy and surgery on complete pathologic response in rectal cancer: a multicenter, randomized, controlled trial (GRECCAR-6). J Clin Oncol 2016;34(31):3773–80. doi: 10.1200/JCO.2016.67.6049.
  8. Барсуков Ю.А., Ткачев С.И., Николаев А.В. и др. Комплексное лечение больных с раком прямой кишки с использованием неоадъювантной термохимиолучевой терапии. Онкологическая колопроктология 2014;(3):23–8.
  9. Brenner D.J. Fractionation and late rectal toxicity. Int J Radiat Oncol Biol Phys 2004;60(4):1013–5. doi: 10.1016/j.ijrobp.2004.04.014.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2019 Tkachev S.I., Abduzhapparov A.S., Aliev V.A., Barsukov Y.A., Madyarov J.M.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77-85909 от  25.08.2023.